Indeed in a phase Ib trial by Pfizer myocarditis was observed in 2 DMD patients after they received an AAV9 vector expressing mini dystrophin; one of the patients died (https://pharmaphorum.com/news/myocarditis-case-mars-sarepta-dmd-gene-therapy-readout/). This evidence concerns the gene DMD and Duchenne muscular dystrophy.